Kernal Biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA. They create mRNA therapies that instruct specific cells on how to make their own drugs, targeting cancers that have resisted other treatments and autoimmune disorders.
- Category
- mRNA Therapeutics
- Stage
- Series A
- Employees
- 25
- HQ
- Cambridge, United States
- Founded
- 2016
- Funding
- $73M